Omiyon
Omiyon is developing a technology that “trains” innovative drugs given to cancer patients to distinguish between healthy cells and cancerous cells, thereby attacking only the diseased cells and avoiding damage to healthy cells.
RAFA Laboratories
Pharmaceutical Manufacturing and Marketing